Clinical Updates
Generic Lidoderm 5% Patch Launches
Actavis Pharma, Inc. has launched generic Lidoderm® (lidocaine patch 5%), which received FDA approval on…
Generic Trilipix Capsules Launch
On July 15, 2013, Global Pharmaceuticals received final FDA approval and commenced shipping for generic…
Generic Zomig Launches
On May 14, 2013, Global Pharmaceuticals launched the Authorized Generic (AG) for Zomig and Zomig-ZMT…
FDA Bans Generic Version of Oxycontin
On the day when the patent for the original version of OxyContin was set to…
Generic Zovirax® Launches
On Wednesday, April 3, generic Zovirax® ointment launched. Annual US brand sales of the 30gm…
Generic Luvox® CR Launches
On March 13, Par Pharmaceuticals received final FDA approval and launched the generic equivalent of…
Changes to the Controlled Substance Schedules – New York
Changes to the Controlled Substance Schedules in Section 3306 of the New York State Public…
Generic Zometa® Launches
Generic Zometa® Launches – On March 5, 2013, Sagent Pharmaceuticals received final FDA approval and…
Generic Suboxone® Launches
On March 5, 2013, Amneal Pharmaceuticals LLC announced that its generic equivalent of Suboxone®, Buprenorphine…
Generic Antara® Launches
On Friday, February 22, Mylan received final FDA approval and launched the generic equivalent of…
